
New Clinical Trial at UTHealth Houston Tests Gene Therapy Vector That Delivers Drug Aimed at Stopping Overactive Bladder ...
A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR Memorial Hermann. Neurogenic bladder, also called …